Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trialGeorgina V. Long, Hussein A. Tawbi, Jun Guo et al.|Nature Medicine|2025Cited by 11
Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098.Georgina V. Long, Hussein A. Tawbi, Paolo A. Ascierto et al.|Journal of Clinical Oncology|2025Cited by 7